MAP2K1 and cancer: This includes the K57E variant that we identified in a single canine sample, which corresponds to the most frequently altered MAP2K1 codon identified in human cancers, and which has been associated with emergence of resistance to BRAF monomer inhibitors in human cancer cells [38].